Oxford Asset Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-118,771
Closed -$1.88M 1029
2019
Q4
$1.88M Sell
118,771
-77,578
-40% -$832K 0.05% 458
2019
Q3
$1.54M Buy
196,349
+134
+0.1% +$1.19K 0.04% 699
2019
Q2
$2.07M Buy
196,215
+53,915
+38% +$554K 0.04% 626
2019
Q1
$1.73M Buy
142,300
+103,387
+266% +$1.29M 0.04% 659
2018
Q4
$401K Buy
+38,913
New +$463K 0.01% 1283
2018
Q2
Sell
-9,032
Closed -$332K 1878
2018
Q1
$332K Buy
+9,032
New +$329K 0.01% 1378

Other funds holding PRTA

Oxford Asset Management's PRTA Position: Q1 2020 in Review

Oxford Asset Management sold out of Prothena Corp (PRTA) in Q1 2020, closing a stake of 118,771 shares — an estimated $1.88M sold.

Oxford Asset Management first reported a position in PRTA in Q1 2018 and held it in 6 quarters. The position peaked at $2.07M in Q2 2019. 129 funds tracked by Wall St. Rank hold PRTA as of Q1 2020.

  • Oxford Asset Management reported no remaining Prothena Corp position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 118,771 Prothena Corp shares in Q1 2020, an estimated $1.88M.
  • Oxford Asset Management first reported a position in Prothena Corp in Q1 2018 and held it in 6 quarters.
  • Oxford Asset Management's Prothena Corp position peaked at $2.07M in Q2 2019.
  • 129 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.